Biểu đồ giá cổ phiếu OCGN
OCGN Thu nhập
Ocugen Inc
$1.45
-2.34%
$-0.03
Khi đóng cửa: May 06, 16:00:00 GMT-4
$1.46
0.35%
$0
Phiên sau giờ: May 06, 20:00:00 GMT-4
Quay lại
Ocugen Inc (OCGN) Thu nhập
Thống kê chính
Giá đóng cửa trước
$1.49
Giá mở cửa
$1.52
Phạm vi ngày
$1.45 - $1.53
Phạm vi 52 tuần
$0.64 - $2.72
Khối lượng
15.4M
Khối lượng trung bình
6.8M
Tỷ suất cổ tức
--
EPS (TTM)
-0.22
Vốn hóa thị trường
$478.7M
OCGN là gì?
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. The company is headquartered in Malvern, Pennsylvania and currently employs 116 full-time employees. The company went IPO on 2014-12-03. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. The company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. The company is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.
